Ten years of direct oral anticoagulants: lessons learned and challenges ahead

被引:1
|
作者
Airaksinen, K. E. Juhani [1 ]
De Sensi, Francesco [2 ]
机构
[1] Turku Univ Hosp, Heart Ctr, Kiinamyllynkatu 4-8, Turku 20520, Finland
[2] Misericordia Hosp, Cardiol Dept, Grosseto, Italy
关键词
NF-KAPPA-B; CANCER; HEART; INTERLEUKIN-1; PGC-1-ALPHA; DOXORUBICIN; MORTALITY; REVEALS; AGE;
D O I
10.1093/eurheartj/ehae061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2178 / 2180
页数:3
相关论文
共 50 条
  • [41] Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
    Serrao, Alessandra
    Malfona, Francesco
    Assanto, Giovanni Manfredi
    Orellana, Maria Gabriela Chavez
    Santoro, Cristina
    Chistolini, Antonio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 625 - 629
  • [42] Identifying Clinical Predictors of Switching From Direct Oral Anticoagulants to Warfarin
    Rollins, Amber
    Hanigan, Sarah
    Pogue, Kristen
    Renner, Elizabeth
    Barnes, Geoffrey
    Dorsch, Michael
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2019, 11
  • [43] Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer
    Ogata, Misato
    Ama, Yumi
    Ogata, Takatsugu
    Hirabatake, Masaki
    Yasui, Hisateru
    Satake, Hironaga
    IN VIVO, 2021, 35 (05): : 2747 - 2753
  • [44] Direct Oral Anticoagulants in Thromboembolism in Patients with Solid Cancer: Can They Be Privileged?
    Abu-Safieh, Omar
    Wiemer, Marcus
    Kaese, Sven
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (03) : 297 - 304
  • [45] Surveillance of Hospital-Acquired Central Line-Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Lessons Learned, Challenges Ahead
    Gaur, Aditya H.
    Bundy, David G.
    Gao, Cuilan
    Werner, Eric J.
    Billett, Amy L.
    Hord, Jeff D.
    Siegel, Jane D.
    Dickens, David
    Winkle, Cindi
    Miller, Marlene R.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (03) : 316 - 320
  • [46] Neutrophils and oral squamous cell carcinoma: lessons learned and future directions
    Magalhaes, Marco A. O.
    Glogauer, Judah E.
    Glogauer, Michael
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (05) : 695 - 702
  • [47] Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm
    Wojtukiewicz, Marek Z.
    Skalij, Piotr
    Tokajuk, Piotr
    Politynska, Barbara
    Wojtukiewicz, Anna M.
    Tucker, Stephanie C.
    Honn, Kenneth V.
    CANCERS, 2020, 12 (05)
  • [48] HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead
    Moelken, Maureen Rutten-van
    Versteegh, Matthijs
    Nagy, Balazs
    Wordsworth, Sarah
    PERSONALIZED MEDICINE, 2023, 20 (04) : 299 - 303
  • [49] Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants
    Kaneda, Kazuhisa
    Yamashita, Yugo
    Morimoto, Takeshi
    Chatani, Ryuki
    Nishimoto, Yuji
    Ikeda, Nobutaka
    Kobayashi, Yohei
    Ikeda, Satoshi
    Kim, Kitae
    Inoko, Moriaki
    Takase, Toru
    Tsuji, Shuhei
    Oi, Maki
    Takada, Takuma
    Otsui, Kazunori
    Kimura, Takeshi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 118 : 59 - 72
  • [50] Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation
    Rubino, Claudia
    Blunda, Fabiana
    Bodega, Francesca
    Melillo, Francesco
    Russi, Anita
    Mattiello, Paolo
    Salerno, Anna
    Cera, Michela
    Margonato, Davide
    Mazzone, Patrizio
    Della Bella, Paolo
    Castiglioni, Alessandro
    Alfieri, Ottavio
    Debonis, Michele
    Montorfano, Matteo
    Filippi, Massimo
    Tresoldi, Moreno
    Cappelletti, Alberto
    Zangrillo, Alberto
    Margonato, Alberto
    Godino, Cosmo
    MINERVA MEDICA, 2023, 114 (02) : 137 - 147